"Anticoagulants" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Agents that prevent BLOOD CLOTTING.
Descriptor ID |
D000925
|
MeSH Number(s) |
D27.505.954.502.119
|
Concept/Terms |
Anticoagulants- Anticoagulants
- Anticoagulation Agents
- Agents, Anticoagulation
- Anticoagulant Agents
- Agents, Anticoagulant
- Anticoagulant Drugs
- Drugs, Anticoagulant
- Anticoagulant
|
Below are MeSH descriptors whose meaning is more general than "Anticoagulants".
Below are MeSH descriptors whose meaning is more specific than "Anticoagulants".
This graph shows the total number of publications written about "Anticoagulants" by people in this website by year, and whether "Anticoagulants" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1996 | 0 | 1 | 1 |
1997 | 1 | 2 | 3 |
1998 | 1 | 1 | 2 |
1999 | 1 | 3 | 4 |
2000 | 3 | 0 | 3 |
2001 | 2 | 1 | 3 |
2002 | 4 | 6 | 10 |
2003 | 10 | 3 | 13 |
2004 | 15 | 3 | 18 |
2005 | 9 | 12 | 21 |
2006 | 8 | 9 | 17 |
2007 | 4 | 4 | 8 |
2008 | 11 | 6 | 17 |
2009 | 10 | 5 | 15 |
2010 | 11 | 8 | 19 |
2011 | 14 | 4 | 18 |
2012 | 17 | 11 | 28 |
2013 | 19 | 9 | 28 |
2014 | 15 | 10 | 25 |
2015 | 17 | 5 | 22 |
2016 | 18 | 14 | 32 |
2017 | 20 | 14 | 34 |
2018 | 17 | 6 | 23 |
2019 | 17 | 11 | 28 |
2020 | 20 | 18 | 38 |
2021 | 8 | 24 | 32 |
2022 | 3 | 35 | 38 |
2023 | 2 | 24 | 26 |
2024 | 0 | 3 | 3 |
To return to the timeline,
click here.
Below are the most recent publications written about "Anticoagulants" by people in Profiles.
-
Anticoagulation with osocimab in patients with kidney failure undergoing hemodialysis: a randomized phase 2 trial. Nat Med. 2024 Feb; 30(2):435-442.
-
Dabigatran for Treatment and Secondary Prevention of Venous Thromboembolism in Pediatric Congenital Heart Disease. J Am Heart Assoc. 2024 Feb 20; 13(4):e028957.
-
Testing of an Electronic Clinical Quality Measure for Diagnostic Delay of Venous Thromboembolism (DOVE) in Primary Care. AMIA Annu Symp Proc. 2023; 2023:339-348.
-
Apixaban for Prevention of Thromboembolism in Pediatric Heart?Disease. J Am Coll Cardiol. 2023 12 12; 82(24):2296-2309.
-
Severity of Ischemic Stroke After Left?Atrial Appendage Closure vs Nonwarfarin Oral Anticoagulants. JACC Clin Electrophysiol. 2024 Feb; 10(2):270-283.
-
Safety and Effectiveness of Direct Oral Anticoagulants for the Treatment of Gastrointestinal Cancer-Associated Venous Thromboembolism. Oncologist. 2023 Nov 02; 28(11):e1005-e1016.
-
Concomitant Left Atrial Appendage Occlusion and Transcatheter Aortic Valve Replacement Among Patients With Atrial Fibrillation. Circulation. 2024 Mar 05; 149(10):734-743.
-
Systemic anticoagulation in ECMO. Semin Pediatr Surg. 2023 Aug; 32(4):151333.
-
Systemic Anticancer Therapy and Thromboembolic Outcomes in Hospitalized Patients With Cancer and COVID-19. JAMA Oncol. 2023 Oct 01; 9(10):1390-1400.
-
Kidney function and the comparative effectiveness and safety of direct oral anticoagulants vs. warfarin in adults with atrial fibrillation: a multicenter observational study. Eur Heart J Qual Care Clin Outcomes. 2023 09 12; 9(6):621-631.